Pacertool develops PaCRTool, a highly differentiated and proprietary solution to improve cardiac resynchronization therapy (CRT) in heart failure patients. PaCRTool provides healthcare professionals with quantifiable evidence to determine when CRT is effectively applied to heart failure patients and ensure synergy from biventricular pacing. The technology addresses the two big unmet needs in pacing for heart failure patients: patient selection and verified lead placement.
The company focusses on the US market and is implementing a 510(k) strategy in parallell with early safety & feasibility clinical data.
The company focusses on the US market and is implementing a 510(k) strategy in parallell with early safety & feasibility clinical data.
Location: Norway, Oslo
Employees: 1-10
Founded date: 2019
Investors 3
| Date | Name | Website |
| 12.07.2023 | Planet 9 C... | planet9ven... |
| - | Farvatn Ve... | farvatnven... |
| - | Sarsia | sarsia.com |
Mentions in press and media 3
| Date | Title | Description |
| 06.10.2022 | Pacertool Establishes World-Class Scientific Advisory Board | The SAB Will Develop the Company Clinical Trial Strategy Aligned to Current Trends in Cardiac Pacing and Provide Input to the Pacertool Innovation Pipeline. OSLO, VIKEN, NORWAY, October 6, 2022 /EINPresswire.com/ -- Pacertool AS, a Norwegia... |
| 04.10.2022 | Pacertool Establishes World-Class Scientific Advisory Board | The Scientific Advisory Board Will Develop the Company Clinical Trial Strategy, Ensure Alignment with Current Trends in Cardiac Pacing for Heart Failure Patients and Provide Input to the Pacertool Innovation Pipeline. OSLO, Norway, Oct. 4, ... |
| 04.10.2022 | Pacertool Establishes World-Class Scientific Advisory Board | The Scientific Advisory Board Will Develop the Company Clinical Trial Strategy, Ensure Alignment with Current Trends in Cardiac Pacing for Heart Failure Patients and Provide Input to the Pacertool Innovation Pipeline. OSLO, Norway, Oct. 4, ... |